Vitalhub (TSE:VHI – Get Free Report) had its price objective dropped by Scotia from C$12.00 to C$9.00 in a research note issued to investors on Monday, BayStreet reports. The brokerage presently has a “sector outperform” rating on the stock. Scotia‘s price target would indicate a potential upside of 33.73% from the stock’s previous close.
VHI has been the subject of several other research reports. Canaccord Genuity Group set a C$15.00 target price on shares of Vitalhub and gave the stock a “buy” rating in a research note on Friday, August 28th. ATB Cormark Capital Markets lowered their price target on shares of Vitalhub from C$12.00 to C$10.25 and set an “outperform” rating on the stock in a research report on Monday. Finally, TD dropped their price target on shares of Vitalhub from C$13.00 to C$9.50 and set a “buy” rating on the stock in a research note on Monday. Eight analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of C$10.86.
Check Out Our Latest Analysis on VHI
Vitalhub Stock Performance
Vitalhub (TSE:VHI – Get Free Report) last announced its quarterly earnings data on Thursday, November 12th. The company reported C$0.04 earnings per share (EPS) for the quarter. The business had revenue of C$31.91 million for the quarter. Vitalhub had a return on equity of 4.03% and a net margin of 8.63%. As a group, research analysts predict that Vitalhub will post 0.23 earnings per share for the current fiscal year.
Key Vitalhub News
Investors following VHI have been watching these news items:
- Positive Sentiment: Despite reducing their targets, Scotia, Stifel, TD, National Bank Financial, Raymond James, Canaccord Genuity and ATB Cormark retained “buy,” “outperform” or “sector outperform” ratings. Their revised targets range from C$9.00 to C$14.50, still above the recent share price. Scotia analyst coverage
- Neutral Sentiment: A Seeking Alpha article discusses Vitalhub digesting acquisitions while preparing for more; the headline points to acquisition execution and future deals as areas for investors to monitor. Vitalhub: Digesting Acquisitions While Preparing For More
- Negative Sentiment: Royal Bank of Canada downgraded Vitalhub from “moderate buy” to “hold,” also reported as a shift to “sector perform.” The downgrade adds a cautious signal amid the broader round of reduced price targets. Vitalhub Downgraded to Sector Perform at RBC
About Vitalhub
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
See Also
- Five stocks we like better than Vitalhub
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
